NCT01878669View on ClinicalTrials.gov

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

390

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2026

Conditions

Coronary Artery Disease

Interventions

DRUG

N-acetyl cysteine

DRUG

Saline

Trial Locations (1)

32260

Suleyman Demirel University, Isparta

All Listed Sponsors

lead

Suleyman Demirel University

OTHER